Related Experiment Videos
Routine hepatitis B immunisation in India: cost-effectiveness assessment
1Research Fogarty International Center NIH, Bethesda, MD 20892-2220, USA. millermark@who.ch
Indian Journal of Pediatrics
|July 6, 2000
Abstract:
Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.